SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000812796-05-000033
Filing Date
2005-12-12
Accepted
2005-12-12 16:38:09
Documents
2
Period of Report
2005-12-12
Effectiveness Date
2005-12-12

Document Format Files

Seq Description Document Type Size
1 DOR PROXY 2005 proxy2005.htm DEF 14A 615849
2 GRAPH 2005 graph2005.jpg GRAPHIC 84158
  Complete submission text file 0000812796-05-000033.txt   733586
Mailing Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139
Business Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139 305-534-3383
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-16929 | Film No.: 051258678
SIC: 2834 Pharmaceutical Preparations